Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Pharma Industry Analysis

UpdatedAug 26, 2026
DataAggregated Company Financials
Companies58
  • 7D1.8%
  • 3M2.7%
  • 1Y-27.5%
  • YTD-18.9%

The Pharma industry is up 1.8% in the last week, with Bora Pharmaceuticals up 13%. During this same period, the Pharmasaga underperformed, falling 10%. In contrast, the industry has lost 28% in the last 12 months. Earnings are forecast to grow by 96% annually.

Industry Valuation and Performance

Has the Taiwanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 26 Aug 2026NT$606.0bNT$128.3bNT$11.7b16.5x51.9x4.7x
Fri, 24 Jul 2026NT$599.1bNT$123.1bNT$18.9b18.1x31.6x4.9x
Sun, 21 Jun 2026NT$615.5bNT$123.1bNT$18.9b17.7x32.5x5x
Tue, 19 May 2026NT$590.8bNT$122.8bNT$18.7b16x31.5x4.8x
Thu, 16 Apr 2026NT$635.4bNT$119.5bNT$20.8b14.8x30.6x5.3x
Sat, 14 Mar 2026NT$661.3bNT$119.3bNT$19.9b15.1x33.3x5.5x
Mon, 09 Feb 2026NT$797.3bNT$119.3bNT$12.4b17x64.2x6.7x
Wed, 07 Jan 2026NT$727.2bNT$118.0bNT$12.3b16.6x59.1x6.2x
Fri, 05 Dec 2025NT$806.6bNT$118.0bNT$12.3b16.9x65.6x6.8x
Sun, 02 Nov 2025NT$752.1bNT$118.3bNT$9.6b16x78.1x6.4x
Tue, 30 Sep 2025NT$818.9bNT$118.3bNT$9.6b16.5x85.3x6.9x
Thu, 28 Aug 2025NT$813.0bNT$118.4bNT$10.3b16.4x78.9x6.9x
Sat, 26 Jul 2025NT$692.6bNT$116.0bNT$14.3b18.4x48.5x6x
Mon, 23 Jun 2025NT$661.6bNT$115.9bNT$14.3b18.5x46.4x5.7x
Wed, 21 May 2025NT$590.0bNT$115.9bNT$14.3b19.3x41.4x5.1x
Fri, 18 Apr 2025NT$530.3bNT$112.8bNT$10.8b18x49x4.7x
Sun, 16 Mar 2025NT$644.9bNT$113.3bNT$12.2b20.3x52.7x5.7x
Tue, 11 Feb 2025NT$663.0bNT$109.3bNT$11.4b22.8x58x6.1x
Thu, 09 Jan 2025NT$606.1bNT$109.3bNT$11.4b22.4x53x5.5x
Sat, 07 Dec 2024NT$610.3bNT$109.3bNT$11.5b22x53x5.6x
Mon, 04 Nov 2024NT$635.4bNT$104.7bNT$8.9b27.2x71.1x6.1x
Wed, 02 Oct 2024NT$646.3bNT$104.7bNT$8.9b25.6x72.3x6.2x
Fri, 30 Aug 2024NT$659.5bNT$104.7bNT$8.9b27x73.8x6.3x
Sun, 28 Jul 2024NT$678.8bNT$100.5bNT$6.8b31.7x99.4x6.8x
Tue, 25 Jun 2024NT$653.6bNT$100.4bNT$7.2b31.2x91.3x6.5x
Thu, 23 May 2024NT$626.7bNT$100.4bNT$7.1b31x87.7x6.2x
Sat, 20 Apr 2024NT$628.0bNT$101.8bNT$9.3b25.9x67.2x6.2x
Mon, 18 Mar 2024NT$616.5bNT$100.9bNT$9.5b25x65x6.1x
Wed, 14 Feb 2024NT$597.8bNT$101.6bNT$8.2b23.4x73.3x5.9x
Fri, 12 Jan 2024NT$574.4bNT$101.9bNT$7.8b23.8x73.7x5.6x
Sun, 10 Dec 2023NT$577.9bNT$101.6bNT$7.6b23.8x75.8x5.7x
Tue, 07 Nov 2023NT$557.3bNT$101.8bNT$9.7b22.5x57.5x5.5x
Thu, 05 Oct 2023NT$550.4bNT$101.7bNT$9.6b21.5x57.2x5.4x
Sat, 02 Sep 2023NT$560.9bNT$101.7bNT$9.6b22.5x58.3x5.5x
Price to Earnings Ratio

58.3x


Total Market Cap: NT$560.9bTotal Earnings: NT$9.6bTotal Revenue: NT$101.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Pharma Industry Price to Earnings3Y Average 60.9x202420252026
Current Industry PE
  • Investors are pessimistic on the Taiwanese Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 51.9x which is lower than its 3-year average PE of 60.9x.
  • The 3-year average PS ratio of 5.8x is higher than the industry's current PS ratio of 4.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 6.6% per year over the last three years.
  • Revenues for these companies have grown 8.1% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market-0.30%
Healthcare4.41%
Pharma1.77%
Pharma1.77%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6472 Bora PharmaceuticalsNT$458.0013.1%
+NT$6.8b		-37.8%PE32.1x
6919 Caliway BiopharmaceuticalsNT$106.003.4%
+NT$5.4b		-46.2%PS5609.2x
1795 Lotus PharmaceuticalNT$195.504.8%
+NT$2.4b		-0.5%PE13.8x
7754 AnnJi PharmaceuticalNT$58.908.9%
+NT$484.5m		26.4%PS6199.5x
4105 TTY BiopharmNT$78.301.7%
+NT$323.2m		1.7%PE11.2x

Latest News

6919
NT$106.00
Caliway Biopharmaceuticals
7D
3.4%
1Y
-46.2%
6472
NT$458.00
Bora Pharmaceuticals
7D
13.1%
1Y
-37.8%
1795
NT$195.50
Lotus Pharmaceutical
7D
4.8%
1Y
-0.5%
4114
NT$29.90
Synmosa Biopharma
7D
-1.2%
1Y
-8.8%
6467
NT$139.00
Taho Pharmaceuticals
7D
3.3%
1Y
-11.5%
6586
NT$111.00
CHO Pharma
7D
-0.4%
1Y
188.7%
4746
NT$49.40
Formosa Laboratories
7D
-5.0%
1Y
-26.8%
4123
NT$32.15
Center Laboratories
7D
-0.8%
1Y
-4.9%
1720
NT$57.20
Standard Chemical & Pharmaceutical
7D
2.1%
1Y
11.6%
6932
NT$5.20
Merdury Biopharmaceutical
7D
-6.0%
1Y
-39.1%
3705
NT$55.80
YungShin Global Holding
7D
2.0%
1Y
-0.4%
4105
NT$78.30
TTY Biopharm
7D
1.7%
1Y
1.7%
8279
NT$81.00
Syngen BiotechLtd
7D
-4.3%
1Y
-34.1%
7878
NT$137.50
Pharmasaga
7D
-10.4%
1Y
n/a
6634
NT$58.70
Sinew Pharma
7D
-2.0%
1Y
21.9%
7754
NT$58.90
AnnJi Pharmaceutical
7D
8.9%
1Y
26.4%